Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Sonic Healthcare Limited ( (AU:SHL) ) is now available.
Sonic Healthcare Limited has announced the cessation of Colin Stephen Goldschmidt as a director, effective November 20, 2025. The notice details Goldschmidt’s interests in various securities, including ordinary shares, unlisted options, and performance rights, which are part of the company’s employee option and performance rights plans. This transition may impact the company’s governance structure and could have implications for its strategic direction and stakeholder relations.
The most recent analyst rating on (AU:SHL) stock is a Hold with a A$23.50 price target. To see the full list of analyst forecasts on Sonic Healthcare Limited stock, see the AU:SHL Stock Forecast page.
More about Sonic Healthcare Limited
Sonic Healthcare Limited operates in the healthcare industry, primarily focusing on providing medical diagnostic services. The company is known for its comprehensive range of laboratory and radiology services, catering to both local and international markets.
Average Trading Volume: 1,723,497
Technical Sentiment Signal: Sell
Current Market Cap: A$10.62B
For a thorough assessment of SHL stock, go to TipRanks’ Stock Analysis page.